DEtecting MicrovAscular dysfunction with Non-obstructive coronary artery Disease in Heart Failure - Multi-center, prospective, observational study - - DEMAND-HF

Yokohama City University Medical Center0 个研究点目标入组 500 人开始时间: 2022年6月21日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patient with heart failure due to ischemic heart disease defined as prior myocardial infarction and/or significant obstructive coronary artery at coronary artery trees defined as stenosis greater than or equal to 75% on visual evaluation and/or fractional flow reserve (FFR) less than or equal to 0.8. 2) Patient with severe valvular heart disease. 3) Patient with congenital heart disease. 4) Patient with chronic kidney disease (eGFR less than 30 ml/min/1.73m2) or on chronic hemodialysis (and/or peritoneal dialysis). 5) Patient with heart failure due to hyperthyroidism. 6) Patient with persistent tachycardia (heart rate greater than or equal to 100bpm) at the evaluation of coronary physiology. 7) Patient with heart failure due to severe anemia less than 8.0 g/dl or requiring blood transfusion. 8) Patient who cannot regularly visit a hospital or patient with a life expectancy less than or equal to 24 months due to terminally non-cardiac illness.

发起方